Effects of CB1 Antagonist/Reverse Agonist Rimonabant on Walking Abilities in Incomplete Spinal Cord Injury

NCT05622994 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Spinal Cord Injuries

Interventions

DRUG: Rimonabant

Sponsor

Hospital Nacional de Parapléjicos de Toledo